Skip to main content
. 2022 Apr 14;14(8):1986. doi: 10.3390/cancers14081986

Table 2.

Cytogenetic risk assigned by conventional karyotype according to the IPSS-R classification vs. that obtained from the CNV plot generated by Haematology OncoKitDX.

Patient Number Gender Karyotype Identified by the Hospital IPSS-R Cytogenetic Risk Groups CNV Plot Identified by Haematology OncoKitDx IPSS-R Cytogenetic Risk Groups Hospital vs. Haematology OncoKitDx
1 Male 46,XY[20] Good 46, XY Good Match
2 Male 46,XY[20] Good 46, XY Good Match
3 Male 46,XY,t(3;12)(q26;p13),del(5)(q12q33),del(11)(q12)[20] Poor 46, XY: 5qdel, 11qdel Intermediate Disparity
4 Male 45,XY,del(5)(q13q34),del(7)(q31),del(12)(p11),t(16;18)(q12;q11),−17[13]/46,XY,del(5)(q13q34)[7] Very Poor 45, XY: 5qdel, 7pdel, 7qdel, 17pdel, 18del Very Poor Match
5 Male 46,XY[20] Good 46, XY Good Match
6 Female 45,XX,−3,del(5)(q13q31),der(6)t(3;6)(q11;p25)[8] Poor 46, XX: 3pdel, 5qdel, 6pgain, 6pdel Very Poor Disparity
7 Female 46,XX,del(5)(q13q31) Good 46, XX, 5qdel Good Match
8 Male 46,XY[20] Good 46, XY Good Match
9 Male 46,XY,del(20)(q11.21q11.31)[16]/46,XY[4] Good 46, XY; 20qdel Good Match
10 Female 46,XX,del(5)(q13q31) Good 46, XX, 5qdel Good Match
11 Female 45,XX,-7[12] Poor 45, XX: 7del Poor Match
12 Female 45–48,XX,del(5)(q13q31),t(3;11)(p21,p15),+2mar[cp8]/45–48,XX,del(5),add(2)(q33),+1mar[cp4]/45–48,XX,del(5),+2,−3,+2mar[cp4] Very Poor 47, XX: 1pgain, 3pdel, 5qdel, 18qdel, 19gain, 20pgain, 20qdel Very Poor Match
13 Male 46,XY,del(20)(q11.2q13.3)[18]/46,XY[2] Good 46, XY: 20qdel Good Match
14 Female 47,XX,+8[14]/46,XX[6] Intermediate 47, XX: 8gain Intermediate Match
15 Male 46,XY[20] Good 46, XY Good Match
16 Female 46,XX,del(5)(q13q31)[16]/46,XX[4] Good 46, XX, 5qdel Good Match
17 Male 46,XY,add(7)(p10),i(17)(q10)[20] Intermediate 46, XY: 1pdel, 3qgain, 7pdel, i17 Very Poor Disparity